Market research
000930.SHE COFCO Biotechnology Co., Ltd
SHE CNY Basic Materials
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 10B
- P/E ratio
- Not available
- Analyst target
- 7.7
- Dividend yield
- 0.5%
- Beta
- 0.21
Profile
Company facts
- Exchange
- SHE
- Currency
- CNY
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- ISIN
- CNE000000ZR7
- Market cap
- 10B
- P/E ratio
- Not available
- Analyst target
- 7.7
- Dividend yield
- 0.5%
- Beta
- 0.21
About
About COFCO Biotechnology Co., Ltd
COFCO Biotechnology Co., Ltd., together with its subsidiaries, engages in the processing of agricultural products in China. The company offers ethanol disinfectants, pharmaceutical ethanol, edible alcohol, anhydrous ethanol, and denatured fuel ethanol; edible corn starch; and flavoring, glucose, malt, and high fructose syrup. It also provides food additives and others, such as corn crude oil, phytosterol red yeast rice tea polyphenol tablets, natural vitamin E soft capsules, phytosterols, and vitamin E; corn germ meal, sprayed corn husks, corn protein powder, and corn dried alcohol distillers; and polylactic acid products. The company was formerly known as COFCO Biochemical (Anhui) Co., Ltd. and changed its name to COFCO Biotechnology Co., Ltd. in September 2019. The company was founded in 1998 and is based in Chaoyang, China.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 000930.SHE discussion.
5 years, 5 months ago
COFCO Biotechnology Co., Ltd is currently in a long term uptrend where the price is trading 0.3% above its 200 day moving average.
From a valuation standpoint, the stock is 77.6% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.9.
COFCO Biotechnology Co., Ltd's total revenue sank by 6.3% to $5B since the same quarter in the previous year.
Its net income has dropped by 17.1% to $168M since the same quarter in the previous year.
Finally, its free cash flow fell by 94.7% to $111M since the same quarter in the previous year.
Based on the above factors, COFCO Biotechnology Co., Ltd gets an overall score of 2/5.